What changed
loanDepot received an NYSE deficiency letter on August 21 because its Class A common stock average closing price was below $1.00 over a consecutive 30 trading-day period as of August 20, 2026. The notice has no immediate impact on NYSE trading or business operations. loanDepot has a six-month cure period and may pursue a reverse stock split, subject to stockholder approval no later than its annual meeting anticipated for early June 2027.
Why it matters
loanDepot received an NYSE deficiency letter on August 21 because its Class A common stock average closing price was below $1.00 over a consecutive 30 trading-day period as of August 20, 2026. The notice has no immediate impact on NYSE trading or business operations. loanDepot has a six-month cure period and may pursue a reverse stock split, subject to stockholder approval no later than its annual meeting anticipated for early June 2027.